StockWatch
·
Healthcare Research- Analytics & Technology
Quarterly Result30 May 2026, 09:31 am

Bilcare Ltd Board Approves FY26 Audited Results

AI Summary

Bilcare Limited's Board of Directors approved the standalone and consolidated audited financial results for the quarter and year ended March 31, 2026. The board did not recommend any dividend for the year. The company redeemed 1,56,00,000 preference shares of Caprihans India Limited and converted 10,40,000 warrants into equity shares of Caprihans India Limited. The Board Meeting commenced at 15:30 (IST) and concluded at 23:55 (IST).

Key Highlights

  • Standalone and consolidated audited financial results for FY26 approved.
  • No dividend recommended for the year ended March 31, 2026.
  • Redemption of 1,56,00,000 Preference Shares of Caprihans India Limited.
  • Conversion of 10,40,000 warrants into equity shares of Caprihans India Limited.
  • Net Loss for the period (5-6) ₹(6.35) Crores.